Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Spruce Biosciences (SPRB)
NASDAQ:SPRB
Spruce Biosciences (SPRB) Stock Price & Analysis
176 Followers
SPRB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.95 - $3.57
Previous Close$2.34
Volume277.41K
Average Volume (3M)151.22K
Market Cap
$92.81M
Enterprise Value-$21.25M
Total Cash (Recent Filing)$118.58M
Total Debt (Recent Filing)$4.52M
Price to Earnings (P/E)-1.3
Beta1.13
Next Earnings
Aug 09, 2023EPS Estimate
-$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.86
Shares Outstanding39,746,116
10 Day Avg. Volume335,129
30 Day Avg. Volume151,225
Standard Deviation0.39
R-Squared0.10
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.99
Price to Sales (P/S)46.40
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-10.63
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.44
Forecast
1Y Price Target
$6.67Price Target Upside185.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Spruce Biosciences News
Stock Analysis & Ideas2 “Strong Buy” Penny Stocks With Multibagger Potential
Stock Analysis & Ideas2 “Strong Buy” Stocks Under $10 With Strong Growth Prospects
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SPRB FAQ
What was Spruce Biosciences’s price range in the past 12 months?
Spruce Biosciences lowest stock price was $0.95 and its highest was $3.57 in the past 12 months.
What is Spruce Biosciences’s market cap?
Currently, no data Available
When is Spruce Biosciences’s upcoming earnings report date?
Spruce Biosciences’s upcoming earnings report date is Aug 09, 2023 which is in 65 days.
How were Spruce Biosciences’s earnings last quarter?
Spruce Biosciences released its earnings results on May 15, 2023. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.221 by -$0.179.
Is Spruce Biosciences overvalued?
According to Wall Street analysts Spruce Biosciences’s price is currently Undervalued.
Does Spruce Biosciences pay dividends?
Spruce Biosciences does not currently pay dividends.
What is Spruce Biosciences’s EPS estimate?
Spruce Biosciences’s EPS estimate is -$0.4.
How many shares outstanding does Spruce Biosciences have?
Spruce Biosciences has 39,746,117 shares outstanding.
What happened to Spruce Biosciences’s price movement after its last earnings report?
Spruce Biosciences reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.221. Following the earnings report the stock price went down -2.242%.
Which hedge fund is a major shareholder of Spruce Biosciences?
Among the largest hedge funds holding Spruce Biosciences’s share is Omega Fund Management, LLC. It holds Spruce Biosciences’s shares valued at 5M.
---
Spruce Biosciences Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.67 (185.65% Upside)
$6.67 (185.65% Upside)
Insider Transactions
Bought Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 0.6%
Last 30 Days ▲ 0.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.67%
12-Months-Change
Fundamentals
Return on Equity
-45.34%
Trailing 12-Months
Asset Growth
20.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Spruce Biosciences
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
---
Top 5 ETFs holding SPRB
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold SPRB. The ETFs are listed according to market value of SPRB within the ETF
---
---